UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)  May 1, 2009


NVE Corporation

(Exact name of registrant as specified in its charter)

 

Minnesota

000-12196

41-1424202

(State or other jurisdiction of incorporation)

(Commission File Number)
(IRS Employer Identification No.)


11409 Valley View Road, Eden Prairie, Minnesota

55344

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code (952) 829-9217

                                                                                                                                
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 1.01 Entry into a Material Definitive Agreement

General information
     Phonak AG has and continues to develop, manufacture, and sell hearing systems using our spintronic medical sensors.

Description of the Terms and Conditions of the Agreement
     On May 1, 2009 we executed a Supply Agreement by and between us and Phonak. The agreement has a term of three years. The agreement establishes purchase forecasts, inventory requirements, ordering conditions, delivery time, performance indicators, requirements for handling corrective actions, terms relating to liability and indemnification, terms relating to intellectual property rights, terms relating to supplier indemnification, confidentiality obligations, and certain other terms and conditions.




2



Item 9.01 Financial Statements and Exhibits
 
Exhibit #
Description
 
10
Supply Agreement by and between NVE Corporation and Phonak AG.

 

 

 

3



SIGNATURE
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date  May 6, 2009 NVE CORPORATION
           (Registrant)

/s/ DANIEL A. BAKER
      Daniel A. Baker
        President and
Chief Executive Officer

 

 

 

4